The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
Cedars-Sinai Medical Center · Délégation Paris 5 · +25 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,024
total citations
- FWCI
- 79.32
- Percentile
- 100%
- References
- 44
Citations per year
Authors
29- MHMark HaasCorresponding
Cedars-Sinai Medical Center
- ALAlexandre LoupyCorresponding
Délégation Paris 5, Inserm, Université Paris Cité
- CLCarmen Lefaucheur
Inserm, Université Paris Cité, Hôpital Saint-Louis, Ecotaxie, Microenvironnement et développement lymphocytaire
- CRCandice Roufosse
North West London Pathology, Imperial College London
- DGDenis Glotz
Inserm, Université Paris Cité, Hôpital Saint-Louis, Ecotaxie, Microenvironnement et développement lymphocytaire
Topics & keywords
Topics
Keywords
- Medicine
- Clinical trial
- Sequela
- Surrogate endpoint
- Kidney transplantation
- Internal medicine
- Pathology
- Kidney
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.